ANZGOG welcomes the Federal Budget’s investment in medical research and clinical trials and highlights the need for continued focus on gynaecological cancers
The Australia New Zealand Gynaecological Oncology Group (ANZGOG) welcomes key initiatives in the Federal Budget that will support Australians living with gynaecological cancer. This includes investment in medical research, clinical trials, Pharmaceutical Benefits Scheme (PBS), Medicare and support for our healthcare workers.
ANZGOG acknowledges the Federal Government’s commitment of $158.6 million over five years to support medical research and the translation of research into clinical practice, alongside the $150.3 million investment in expanding precision oncology programs, including the Australian Rare Cancers Portal. These investments represent a positive step in strengthening Australia’s healthcare system and advancing cancer care.
However, with 19 women diagnosed with a gynaecological cancer every day, and more than half facing a rare or less common cancer with limited treatment options and poor survival rates, ANZGOG recognises the critical need for increased investment and collaboration in this area to change treatment, catalyse research and save women’s lives.
ANZGOG Chair, Professor Clare Scott AM, said the organisation is committed to working with government and the broader health sector to ensure women with gynaecological cancers receive the same level of research investment and treatment innovation as those diagnosed with other cancers.
“With the number of Australian women impacted by gynaecological cancer rising, it is essential that we continue to strengthen research and clinical trial investment to drive better outcomes. ANZGOG stands ready to collaborate with government, the health sector, and research partners to support, connect and implement these important initiatives.”
ANZGOG looks forward to working with the Federal Government to build on these Budget measures, as well as partnering with the Medical Research Future Fund, the Australian Cancer Plan, and the National Framework for Genomics in Cancer Control.
Through targeted investment and transformative research, we can improve the diagnosis, treatment, and care of gynaecological cancers—delivering better outcomes for all those affected.
Media inquiries: Monique Cerreto T: 0416 282 464 E: Monique.cerreto@anzgog.org.au
